Jazz Pharmaceuticals to acquire Actio Biosciences for $820 million

56 minutes ago

Eli Lilly takes weight-loss pill battle global

56 minutes ago

Trump signs order calling for fewer childhood vaccines, falsely linking shots to autism

6 hours ago

New genetic tests are catching rare diseases before symptoms start

20 hours ago

Why we like Boeing's latest deal — plus, what to expect from this health stock

22 hours ago

Hunter Biden says Joe Biden's cancer has spread further, 'very painful'

23 hours ago

Cyclospora fears lead consumers to lose their appetite for salads

3 days ago

Jim Cramer highlights 5 investing themes — and the stocks to buy for each

4 days ago

Sen. Mitch McConnell says he's left rehab, will work from home

4 days ago

CAMP4 advances rare disease treatment for SYNGAP1 into human trials

4 days ago

Divide between Eli Lilly and Novo Nordisk is widening after latest earnings

4 days ago

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale

5 days ago

This stock is more than a way to play GLP-1 boom

5 days ago

Bank of America spends $250M a year on GLP-1 drugs for its employees, CEO says

5 days ago

Eli Lilly blows past estimates, raises outlook on Zepbound and Mounjaro sales

6 days ago

CVS blows past estimates, hikes guidance as insurance unit continues to improve

6 days ago

Novo CEO defends economics of Wegovy pill as lower prices weigh on sales

6 days ago

Chipotle stock falls on potential link to salmonella outbreak in Minnesota

6 days ago

Novo Nordisk shares slide after guidance disappoints investors

6 days ago

P&G will acquire supplements brand Thorne for $3.8 billion, CEO tells CNBC

6 days ago

Pfizer tops estimates, hikes low end of revenue guidance on non-Covid products

7 days ago

Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance

7 days ago

Michigan confirms first two deaths in cyclospora outbreak

7 days ago

AstraZeneca in talks with Bristol Myers Squibb on $400B megadeal, FT reports

7 days ago

Novo Nordisk shares dive after heart medicine fails trial in blow to pipeline

8 days ago

New Medicaid work rules could leave rare disease patients uninsured

11 days ago

AI stocks rebound, and why J&J's earnings guidance cut is not cause for concern

11 days ago

Hims and Hers shares fall 10% as FTC sues company over data, billing practices

12 days ago

Humana tops estimates, maintains profit outlook as medical costs stay in line

12 days ago

Why shareholders are suing Novo Nordisk over next-generation weight-loss drug

13 days ago

Jim Cramer says Wall Street is fleeing the AI trade and buying these stocks instead

13 days ago

Kentucky Gov. Beshear calls on Mitch McConnell to prove he can serve or resign

13 days ago